Online citations, reference lists, and bibliographies.
← Back to Search

Use Of An Emollient As A Steroid‐Sparing Agent In The Treatment Of Mild To Moderate Atopic Dermatitis In Children

A. Lucky, A. Leach, P. Laskarzewski, H. Wenck
Published 1997 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Abstract: The effectiveness of an emollient as an adjunct to topical corticosteroid therapy for the treatment of mild to moderate atopic dermatitis was studied for 3 weeks in 25 children 3 to 15 years of age in comparison with corticosteroid therapy alone. The adjunctive regimen of a once‐daily application each of hydrocortisone 2.5% cream and of a water‐in‐oil cream was equivalent in efficacy to the comparative regimen of twice‐daily applications of hydrocortisone 2.5% cream. Both treatment regimens elicited significant improvement in skin condition by day 7 (p < 0.005) and further significant improvement by day 14 (p < 0.005). No significant differences between the two treatment regimens were observed in the rates of improvement (p > 0.545) or in the reductions in mean lesion size (p > 0.9B). No differences were observed in parental evaluations, except for ease of application where a slight preference was expressed for the hydrocortisone 2.5% cream preparation (p < 0.038). We conclude that emollient adjunct i ve therapy offers a steroid‐sparing alternative to topical corticosteroids alone in the treatment of mild to moderate atopic dermatitis.
This paper references
Topical all-/ra
JA Ixsnik RH. Mezick (1989)
10.1001/ARCHPEDI.1966.02090120086008
Percutaneous absorption of hydrocortisone in children.
B. I. Feinblatt (1966)
Percutaneous absorption of bydrocortisone in children
E. Bruck (1966)
10.1111/j.1365-2133.1976.tb02272.x
The effect of percutaneously absorbed steroids on hypothalamic‐pituitary adrenal function after intensive use in in‐patients *
D. D. Munro (1976)
10.1111/j.1365-2133.1992.tb14847.x
Contact hypersensitivity to topical corticosteroids
A. Burden (1992)
10.1136/adc.57.3.204
Endocrine complications of topical and intralesional corticosteroid therapy.
J. A. Curtis (1982)
Atopic dermatitis: recent therapeutic advances.
Y. de Prost (1992)
Guidcline.s of care for atopic dermatiti.s
Rl Drake LA. Ceilley (1992)
10.1111/j.1525-1470.1992.tb00639.x
Atopic Dermatitis: Recent Therapeutic Advances
Y. Prost (1992)
10.1016/0190-9622(92)70162-9
Topical glucocorticoids with improved benefit/risk ratio: do they exist?
H. C. Korting (1992)
10.1001/ARCHDERM.1980.01640310056019
Risks of unoccluded topical steroids in clinical trials.
W. Akers (1980)
Atopic dermatitis in infant.s and children
J. M. Hanifin (1991)
Atopic dermatitis in infant.s and children. Pcdiair
J M Hanifin (1991)
A prospective computerized .study of 5(X) case.s of atopic dermatiiis in childhood
C Queille-Roussel (1985)
Potential hazards of lopical steroid therapy
G Stoppoloni (1983)
10.1016/S0031-3955(16)38153-6
Atopic dermatitis in infants and children.
J. Hanifin (1991)
10.1016/S0190-9622(89)70159-6
Topical all-trans-retinoic acid prevents corticosteroid-induced skin atrophy without abrogating the anti-inflammatory effect.
R. Lesnik (1989)
10.1001/ARCHPEDI.1982.03970390088024
Cushing's syndrome after topical application of corticosteroids.
R. Ruíz-Maldonado (1982)
Contact hypersensitivily to topical corticosleroids
AD Burden (1992)
[Atopic dermatitis].
I. Lelis (1980)
10.1016/S0190-9622(08)80299-X
Guidelines of care for alopecia areata.
L. Drake (1992)
10.1016/0190-9622(93)70096-C
Atopic dermatitis in children: who cares? Who pays?
C. Lapidus (1993)
10.1016/0190-9622(91)70165-X
Atopic dermatitis: new therapeutic considerations.
J. Hanifin (1991)
Water-in-oil emollients as steroid-sparing adjunctive therapy in the treatment of psoriasis.
K. Watsky (1992)



This paper is referenced by
10.1542/PEDS.110.1.E2
Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
U. Wahn (2002)
Topical steroid or emollient — which to apply first? A critical review of the science and debate
A. Smoker (2014)
10.1111/j.1473-2130.2004.00086.x
Atopic eczema. What has caused the epidemic in industrialised countries and can early intervention modify the natural history of atopic eczema?
K. Thestrup‐Pedersen (2003)
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations. Atopic Dermatitis
H. Williams (2005)
DERM 101 Skin Care for Atopic Dermatitis Bathing
K. Pytkowska (2016)
10.1016/J.IAC.2004.06.011
Topical treatment of atopic dermatitis.
M. Boguniewicz (2004)
10.1016/B978-0-323-37579-5.00011-8
Atopic Dermatitis and Allergic Contact Dermatitis
Donald Y.M. Leung (2017)
10.1080/09546634.2019.1655137
Atopic dermatitis epidemiology and unmet need in the United Kingdom
M. Cork (2019)
10.1111/j.1468-3083.2009.03449.x
Cost‐effectiveness of a barrier‐strengthening moisturizing cream as maintenance therapy vs. no treatment after an initial steroid course in patients with atopic dermatitis in Sweden – with model applications for Denmark, Norway and Finland
F. Hjalte (2010)
10.1111/j.1468-3083.2009.03303.x
Treatment with a barrier‐strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial
K. Wirén (2009)
10.1111/j.1467-2494.2007.00364.x
Increasing quality of life by improving the quality of skin in patients with atopic dermatitis
K. Halvarsson (2007)
What proportion of dermatological patients receive evidence-based treatment?
D. Abeni (2001)
NON-PHARMACOLOGICAL MANAGEMENT OF ATOPIC DERMATITIS , INCLUDING EMOLLIENTS
(2014)
Skin Care for Atopic Dermatitis
Moon Bum Kim (2009)
10.1155/2012/691954
Skin Barrier Protection
G. Stamatas (2012)
10.1046/j.1468-3083.2002.00349.x
Treatment principles of atopic dermatitis
K. Thestrup‐Pedersen (2002)
10.1007/978-90-313-6614-9_53
NHG-Standaard Constitutioneel eczeem
J. Cleveringa (2009)
Efinaconazole: a new topical treatment for onychomycosis.
A. Gupta (2014)
10.2147/CCID.S215023
Emollient formulations containing antiseptics reduce effectively the level of Staphylococcus aureus on skin
Fabrizio Spada (2019)
10.1097/01.all.0000244795.41357.6e
Steroids versus other immune modulators in the management of allergic dermatoses
W. Abramovits (2006)
Atopic Dermatitis in Children Efficacy and Safety of Pimecrolimus Cream in the Long-Term Management of
R. Cherill (2005)
10.1016/S0151-9638(05)86140-X
Utilisation des dermocorticoïdes au cours de la dermatite atopique de l’enfant
F. Cambazard (2005)
10.1016/j.sder.2008.05.001
A multidisciplinary approach to evaluation and treatment of atopic dermatitis.
M. Boguniewicz (2008)
10.1080/00914037.2014.886230
Novel Formable PVA-Based Gel as a Potential for Atopic Dermatitis Treatment
Hong-Ru Lin (2014)
10.5021/ad.2015.27.5.563
Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part I): General Management and Topical Treatment
J. Kim (2015)
10.1007/s13555-018-0228-3
Efficacy and Tolerability of a Medical Device Repairing Emollient Cream Associated with a Topical Corticosteroid in Adults with Atopic Dermatitis: An Open-label, Intra-individual Randomized Controlled Study
A. B. Rossi (2018)
10.1177/0009922807309422
Stepwise Approach to Topical Therapy for Atopic Dermatitis
Christine M Palmer (2008)
10.1080/09546630600552216
Evaluation of a new moisturizer (Exomega milk®) in children with atopic dermatitis
F. Giordano-Labadie (2006)
10.1016/j.jaad.2013.10.010
Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.
L. Eichenfield (2014)
10.1046/j.1439-0353.2003.02021.x
Erfolgreiche Reduktion des SCORAD‐Scores bei Kindern mit atopischem Ekzem im 6‐Wochen‐Vergleich durch Kurzschulung mit einem vereinfachten Hautmodell
B. Kardorff (2003)
10.1097/DER.0b013e3182a745f8
Oat and Wheat as Contact Allergens in Personal Care Products
Suwimon Pootongkam (2013)
10.2147/CCID.S210444
Steroid-sparing effects and acceptability of a new skin gel containing the anti-inflammatory medicinal substance-nicotinamide
Jasmina Djokic-Gallagher (2019)
See more
Semantic Scholar Logo Some data provided by SemanticScholar